06.08.2018 11:00
Munich Cluster for Systems Neurology (SyNergy)
Anirvan Ghosh
Research and Early Development, Biogen, Cambridge, USA

Anti-Amyloid immunotherapy and the first signs of efficacy in Alzheimer’s Disease

Munich Cluster for Systems Neurology (SyNergy)
Center for Stroke and Dementia Research Large Seminar Room 8G U1 155

Host: Christian Haass